| Literature DB >> 29379435 |
Sundas Hira1, Uzma Saleem2, Fareeha Anwar1, Bashir Ahmad1.
Abstract
Aggression is a major hallmark worldwide attributing negative traits in personality. Wide variety of antioxidants is used for the treatment of many ailments. The present study was conducted to evaluate the role of antioxidants such as ascorbic acid (15.42 and 30.84 mg/kg), beta carotene (1.02 and 2.05 mg/kg), vitamin E (2.5 and 5.0 mg/kg), and N-acetyl cysteine (102.85 and 205.70 mg/kg) in the treatment of aggression. Two aggression models (isolation induced aggression model and L-DOPA induced aggression model) were used in the study. Male albino mice (n = 330) were used in the study which were further subdivided into 11 groups (Group I-control, group II-diseased, group III-standard group, group IV-V treated with ascorbic, group VI-VII treated with beta carotene, group VIII-IX treated with vitamin E, group X-XI treated with N-acetyl cysteine for 14 consecutive days). Different biochemical markers (glutathione, superoxide dismutase, and catalase) were determined to evaluate the antioxidant potential in oxidative stress. High dose of vitamin E (5.0 mg/kg) was more effective to reduce the aggression in isolated animals while all other antioxidants produced dose-dependent anti-aggressive effect except N-acetyl cysteine which had marked anti-aggressive effect at low dose (102.75 mg/kg). Low doses of vitamin E (2.5 mg/kg) and N-acetyl cysteine (102.75 mg/kg) and high dose of beta carotene (2.05 mg/kg) were effective to prevent all aggression parameters in acute anti-aggressive activity against L-DOPA induced aggression. However, all test antioxidants were equally effective in chronic anti-aggressive studies against L-DOPA induced aggression. It may be concluded that selected antioxidants can reverse the aggression which is a key symptom of many neurological disorder.Entities:
Keywords: CAT; GSH; L-DOPA; SOD; aggression; antioxidant
Year: 2018 PMID: 29379435 PMCID: PMC5775506 DOI: 10.3389/fphar.2017.00945
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
Anti-aggressive activity of antioxidants against isolation induced aggression.
| Groups | Treatment | Dose (mg/Kg) | Total score |
|---|---|---|---|
| I | Negative control | 0 ± 0.00 | |
| II | Diseased control | Isolation for one month | 100 ± 0.00 |
| III | Standard (Diazepam) | 2.5 | 5.00 ± 5.00 |
| IV | Ascorbic acid | 15.42 | 50.00 ± 17.67 |
| V | 30.85 | 25.00 ± 11.18 | |
| VI | Beta carotene | 1.02 | 45.00 ± 14.57 |
| VII | 2.05 | 40.00 ± 20.31 | |
| VIII | Vitamin E | 2.5 | 45.00 ± 20.00 |
| IX | 5.0 | 15.00 ± 10.00 | |
| X | NAC | 102.85 | 22.00 ± 11.57 |
| XI | 205.70 | 50.00 ± 13.69 |
Acute anti-aggressive activity of antioxidants against L-DOPA induced aggression.
| Groups | Treatment | Dose (mg/Kg) | Aggression parameters after administration of L-DOPA | |||
|---|---|---|---|---|---|---|
| Latency to first bite (Seconds) | Screaming response (No. of screams) | Jumping response (No. of jumps) | Biting response (No. of bites) | |||
| I | Negative control | 0 | 0 | 0 | 0 | |
| II | Standard (diazepam) | 2.5 | 0 | 0 | 0 | 0 |
| III | Diseased control (carbidopa + levodopa) | 4.28 + 375 | 8.6 ± 0.6 | 1.6 ± 0.4 | 2.8 ± 0.5 | 4 ± 0.3 |
| IV | Ascorbic acid | 15.42 | 0 | 0 | 0.6 ± 0.4 | 0 |
| V | 30.84 | 0 | 0.4 ± 0.4 | 0 | 0 | |
| VI | Beta carotene | 1.02 | 0 | 0 | 0.6 ± 0.6 | 0 |
| VII | 2.05 | 0 | 0 | 0 | 0 | |
| VIII | Vitamin E | 2.5 | 0 | 0 | 0 | 0 |
| IX | 5.0 | 0 | 0.8 ± 0.8 | 0 | 0 | |
| X | NAC | 102.85 | 0 | 0 | 0 | 0 |
| XI | 205.70 | 0 | 0.4 ± 0.4 | 0 | 0 | |
Chronic anti-aggressive activity of antioxidants against L-DOP induced aggression.
| Groups | Treatment | Dose (mg/kg) | Aggression parameters after administration of L-DOPA | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Latency to first bite (Seconds) | Screaming response (No. of screams) | Jumping response (No. of jumps) | Biting response (No. of bites) | |||||||
| On 7th Day | On 14th Day | On 7th Day | On 14th Day | On 7th Day | On 14th Day | On 7th Day | On 14th Day | |||
| I | Negative control | NS 0.9% 1ml/kg | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| II | Standard (diazepam) | 2.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| III | Diseased control (carbidopa + levodopa) | 4.28 + 375 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| IV | Ascorbic acid | 15.42 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| V | 30.84 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| VI | Beta carotene | 1.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| VII | 2.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| VIII | Vitamin E | 2.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| IX | 5.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| X | NAC | 102.85 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| XI | 205.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Estimation of endogenous antioxidants in brain tissues in mice having isolation induced aggression.
| Groups | Treatment | Dose (mg/Kg) | GSH (μg/mg of brain tissue) | SOD (μg/mg of brain tissue) | CAT (μg/mg of brain tissue) |
|---|---|---|---|---|---|
| I | Negative control | 2.96 ± 0.39 | 23.16 ± 0.948 | 5.35 ± 0.07 | |
| II | Diseased control | Isolation for 1 month | 1.07 ± 0.25 | 12.78 ± 0.10 | 1.16 ± 0.01 |
| III | Standard (diazepam) | 2.5 | 5.95 ± 0.02*** | 31.08 ± 0.24*** | 4.35 ± 0.07*** |
| IV | Ascorbic acid | 15.42 | 25.10 ± 0.15*** | 71.07 ± 0.04*** | 4.63 ± 0.02*** |
| V | 30.84 | 2.18 ± 0.01*** | 59.67 ± 0.10*** | 5.07 ± 0.01*** | |
| VI | Beta carotene | 1.02 | 17.30 ± 0.204*** | 68.14 ± 0.59*** | 6.64 ± 0.01*** |
| VII | 2.05 | 12.35 ± 0.01*** | 46.44 ± 0.20*** | 8.56 ± 0.02*** | |
| VIII | Vitamin E | 2.5 | 37.36 ± 0.02*** | 84.34 ± 0.10*** | 9.75 ± 0.01*** |
| IX | 5.0 | 36.90 ± 0.09*** | 70.83 ± 0.03*** | 7.54 ± 0.01*** | |
| X | NAC | 102.85 | 25.32 ± 0.16*** | 91.80 ± 0.03*** | 2.54 ± 0.01*** |
| XI | 205.70 | 43.37 ± 0.10*** | 77.02 ± 0.06*** | 4.71 ± 0.01*** |
Estimation of endogenous antioxidants in brain tissues of mice that received L-DOPA to induce aggression.
| Groups | Treatment | Dose (mg/ Kg) | GSH (μg/mg of brain tissue) | SOD (μg/mg of brain tissue) | CAT (μg/mg of brain tissue) |
|---|---|---|---|---|---|
| I | Negative control | 2.96 ± 0.39 | 23.16 ± 0.94 | 5.35 ± 0.07 | |
| II | Diseases control (carbidopa+ levodopa) | 4.28 + 375 | 1.34 ± 0.01 | 10.43 ± 0.03 | 1.151 ± 0.006 |
| III | Standard (diazepam) | 2.5 | 5.95 ± 0.02*** | 31.08 ± 0.24*** | 4.35 ± 0.07*** |
| IV | Ascorbic acid | 15.42 | 3.99 ± 0.05*** | 71.14 ± 0.01*** | 3.58 ± 0.04*** |
| V | 30.84 | 59.46 ± 0.16*** | 95.01 ± 0.06*** | 5.64 ± 0.03*** | |
| VI | Beta carotene | 1.02 | 12.56 ± 0.05*** | 121.5 ± 0.16*** | 8.31 ± 0.16*** |
| VII | 2.05 | 18.68 ± 0.202*** | 165.2 ± 0.16*** | 10.87 ± 0.285*** | |
| VIII | Vitamin E | 2.5 | 5.16 ± 0.06*** | 59.86 ± 0.09*** | 3.34 ± 0.06*** |
| IX | 5.0 | 7.31 ± 0.03*** | 70.85 ± 0.06*** | 7.36 ± 0.04*** | |
| X | NAC | 102.85 | 6.35 ± 0.18*** | 80.56 ± 0.11*** | 2.63 ± 0.02*** |
| XI | 205.70 | 7.61 ± 0.03*** | 98.19 ± 0.06*** | 3.62 ± 0.03*** |